Published in Clin Exp Immunol on February 01, 1991
Visualization of focal sites of transcription within human nuclei. EMBO J (1993) 5.06
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J (1994) 4.29
The RNA 3' cleavage factors CstF 64 kDa and CPSF 100 kDa are concentrated in nuclear domains closely associated with coiled bodies and newly synthesized RNA. EMBO J (1996) 1.42
Compartmentalization within the nucleus: discovery of a novel subnuclear region. J Cell Biol (1991) 1.37
Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol (2010) 0.89
Autoantigens in primary biliary cirrhosis. J Clin Pathol (2000) 0.86
Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci (1997) 0.84
Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders. Clin Exp Immunol (2002) 0.79
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol (1984) 1.67
Identification of human Sm and (U1) RNP antigens by immunoblotting. J Immunol Methods (1983) 1.45
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol (1987) 1.19
Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology (1988) 1.03
Role of estrogen receptor binding and transcriptional activity in the stimulation of hyperestrogenism and nuclear bodies. Proc Natl Acad Sci U S A (1978) 0.85
Antinuclear antibodies in primary biliary cirrhosis. Lancet (1984) 0.84
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus. J Virol (1988) 4.11
Origin of unenveloped capsids in the cytoplasm of cells infected with herpes simplex virus 1. J Virol (1991) 2.52
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol (2000) 1.59
Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study. Am J Gastroenterol (1998) 1.57
Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod (2008) 1.57
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 1.47
Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online (2007) 1.47
Abdominal lymphadenopathy detected by ultrasonography in HIV-1 infection: prevalence and significance. Scand J Infect Dis (1993) 1.44
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis (2001) 1.44
Bile duct cell apoptosis is a rare event in primary biliary cirrhosis. Dig Liver Dis (2001) 1.40
IgA antibodies to endomysium, gliadin, and reticulin in silent coeliac disease. Lancet (1992) 1.40
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet (1991) 1.38
Anti-A autoantibody associated with immune hemolytic anemia. Vox Sang (1991) 1.38
Thyroid function in systemic sclerosis. J Endocrinol Invest (1991) 1.38
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet (1998) 1.33
[Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy?]. Med Trop (Mars) (2003) 1.32
Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet (1990) 1.30
Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
HCV and autoimmunity. Curr Pharm Des (2008) 1.22
Basement membrane production by hepatocytes in chronic liver disease. Hepatology (1985) 1.21
Mitochondrial antibodies in primary biliary cirrhosis. V. Ultrastructural localization of the antigen to the inner mitochondrial membrane using a direct peroxidase conjugate. Br J Exp Pathol (1973) 1.20
IgA antiendomysial antibody test. A step forward in celiac disease screening. Dig Dis Sci (1991) 1.16
Evaluation of serum rosette inhibitory factors in chronic liver disease. Clin Exp Immunol (1983) 1.14
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology (1996) 1.13
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations. Am J Pathol (2000) 1.11
Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis (1997) 1.10
Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. Clin Exp Immunol (1974) 1.10
Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology (1998) 1.09
Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology (1994) 1.09
Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine. Georgian Med News (2008) 1.07
Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol (1989) 1.06
Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. Br J Surg (2014) 1.04
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol (2003) 1.04
Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol (1997) 1.03
Construction of a continent perineal colostomy by using electrostimulated gracilis muscles after abdominoperineal resection: personal technique and experience with 32 cases. Ital J Surg Sci (1987) 1.03
Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis (1988) 1.02
Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol (2002) 1.02
Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut (1995) 1.02
Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver (1994) 1.02
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis (2006) 1.01
Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol (1991) 1.01
Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood (1996) 1.01
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens (2008) 1.01
Relationship between interphasic nucleolar organizer regions and growth rate in two neuroblastoma cell lines. Am J Pathol (1989) 1.01
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther (2005) 1.00
Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol (2000) 1.00
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol (2006) 1.00